Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland
- PMID: 29563170
- PMCID: PMC5898931
- DOI: 10.1183/13993003.01794-2017
Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland
Abstract
While acute respiratory tract infections can trigger cardiovascular events, the differential effect of specific organisms is unknown. This is important to guide vaccine policy.Using national infection surveillance data linked to the Scottish Morbidity Record, we identified adults with a first myocardial infarction or stroke from January 1, 2004 to December 31, 2014 and a record of laboratory-confirmed respiratory infection during this period. Using self-controlled case series analysis, we generated age- and season-adjusted incidence ratios (IRs) for myocardial infarction (n=1227) or stroke (n=762) after infections compared with baseline time.We found substantially increased myocardial infarction rates in the week after Streptococcus pneumoniae and influenza virus infection: adjusted IRs for days 1-3 were 5.98 (95% CI 2.47-14.4) and 9.80 (95% CI 2.37-40.5), respectively. Rates of stroke after infection were similarly high and remained elevated to 28 days: day 1-3 adjusted IRs 12.3 (95% CI 5.48-27.7) and 7.82 (95% CI 1.07-56.9) for S. pneumoniae and influenza virus, respectively. Although other respiratory viruses were associated with raised point estimates for both outcomes, only the day 4-7 estimate for stroke reached statistical significance.We showed a marked cardiovascular triggering effect of S. pneumoniae and influenza virus, which highlights the need for adequate pneumococcal and influenza vaccine uptake. Further research is needed into vascular effects of noninfluenza respiratory viruses.
Copyright ©ERS 2018.
Conflict of interest statement
Conflict of interest: H. Whitaker has received grants from the MRC (methodology grant MR/L009005/1) and IMI/EFPIA (ADVANCE), outside the submitted work.
Figures

Comment in
-
The Baffling Case of Ischemic Stroke Disappearance from the Casualty Department in the COVID-19 Era.Eur Neurol. 2020;83(2):213-215. doi: 10.1159/000507666. Epub 2020 Apr 14. Eur Neurol. 2020. PMID: 32289789 Free PMC article. No abstract available.
Similar articles
-
Acute myocardial infarctions and stroke triggered by laboratory-confirmed respiratory infections in Denmark, 2010 to 2016.Euro Surveill. 2020 Apr;25(17):1900199. doi: 10.2807/1560-7917.ES.2020.25.17.1900199. Euro Surveill. 2020. PMID: 32372757 Free PMC article.
-
Risk of myocardial infarction and stroke after acute infection or vaccination.N Engl J Med. 2004 Dec 16;351(25):2611-8. doi: 10.1056/NEJMoa041747. N Engl J Med. 2004. PMID: 15602021
-
Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes.CMAJ. 2016 Oct 4;188(14):E342-E351. doi: 10.1503/cmaj.151059. Epub 2016 Jul 25. CMAJ. 2016. PMID: 27455981 Free PMC article.
-
The association of influenza infection and vaccine with myocardial infarction: systematic review and meta-analysis of self-controlled case series.Expert Rev Vaccines. 2019 Nov;18(11):1211-1217. doi: 10.1080/14760584.2019.1690459. Epub 2019 Dec 10. Expert Rev Vaccines. 2019. PMID: 31693865
-
Myocardial infarction, stroke, and sudden cardiac death may be prevented by influenza vaccination.Curr Atheroscler Rep. 2003 Mar;5(2):146-9. doi: 10.1007/s11883-003-0087-x. Curr Atheroscler Rep. 2003. PMID: 12573201 Review.
Cited by
-
Prevalence of influenza and other acute respiratory illnesses in patients with acute myocardial infarction in Bangladesh: A cross-sectional study.Health Sci Rep. 2024 Jul 8;7(7):e2234. doi: 10.1002/hsr2.2234. eCollection 2024 Jul. Health Sci Rep. 2024. PMID: 38983680 Free PMC article.
-
Myocardial injury and COVID-19: Serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease.Theranostics. 2020 Jul 29;10(21):9663-9673. doi: 10.7150/thno.47980. eCollection 2020. Theranostics. 2020. PMID: 32863952 Free PMC article.
-
Hospitalisation for lower respiratory tract infection is associated with an increased incidence of acute myocardial infarction and stroke in tropical Northern Australia.Sci Rep. 2021 Mar 25;11(1):6826. doi: 10.1038/s41598-021-86301-3. Sci Rep. 2021. PMID: 33767312 Free PMC article.
-
Impact of Pneumonia on Cognitive Aging: A Longitudinal Propensity-Matched Cohort Study.J Gerontol A Biol Sci Med Sci. 2023 Aug 2;78(8):1453-1460. doi: 10.1093/gerona/glac253. J Gerontol A Biol Sci Med Sci. 2023. PMID: 36526613 Free PMC article.
-
Intravenous Thrombolysis for Stroke in a COVID-19 Positive Filipino Patient, a Case Report.J Clin Neurosci. 2020 Jul;77:234-236. doi: 10.1016/j.jocn.2020.05.006. Epub 2020 May 11. J Clin Neurosci. 2020. PMID: 32414622 Free PMC article.
References
-
- World Health Organization. The top 10 causes of death. www.who.int/mediacentre/factsheets/fs310/en/index.html Date last accessed: July 20, 2017. Date last updated: January, 2017.
-
- Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 2009; 9: 601–610. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical